Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02555644
Title A Study of LY2606368 With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

oropharynx cancer

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

hypopharynx cancer

Therapies

Prexasertib

Cisplatin

Cetuximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.